FDA Inspection 952538 — Pearl Therapeutics, Inc.

Pearl Therapeutics, Inc. — FEI 3011777956

The FDA completed an inspection of Pearl Therapeutics, Inc. on Nov 17, 2015 in Morristown, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Nov 17, 2015
Fiscal Year
2016
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Morristown, NJ (United States)

Additional details

Sponsor, Contract Research Organization

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.